2438-S AMH STOK MERE 560
SHB 2438 - H AMD 1516
By Representative Stokesbary
On page 2, line 34, after "section 4 of this act" strike "and" and insert ","
On page 2, line 35, after "section 5 of this act" insert ", and any penalties received by the state as a result of litigation in which the state is a party against an opioid manufacturer or distributor relating to acts or omissions by the manufacturer or distributor that contributed to increased rates of opioid addiction in Washington"
On page 3, after line 16, insert the following:
"(4) Beginning in fiscal year 2022, if the unobligated balance in the prescription opioid impact account at the end of the fiscal year is at least thirty-two million dollars, the department shall not impose the impact fee required under section 4 of this act during the following fiscal year. If the unobligated balance at the end of any subsequent fiscal year is at least thirty-two million dollars, the prescription opioid fee shall not be applied during the following fiscal year."
On page 3, line 17, after "(1)" strike "If" and insert "Except as provided in section 3 of this act, if"
| EFFECT: (1) Requires that penalties received pursuant to litigation by the state against manufacturers and distributors relating to their acts or omissions that contributed to increased rates of opioid addiction in Washington be placed into the Prescription Opioid Impact Account.
(2) Provides that, beginning in fiscal year 2022, if the unobligated balance in the Opioid Impact Account is at least $32 million, the Department of Health shall not impose the impact fee required under the bill in the following fiscal year. The impact fee may not be re-imposed in a fiscal year after fiscal year 2022 unless the unobligated account balance at the end of the preceding fiscal year is less than $32 million.
|
--- END ---